SCHEMBL13305377

SCHEMBL13305377

Cc1cnn2c(NCc3ccc4[nH]cnc4c3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 8/20 0.53
▸ GSK3B P49841 8/20 0.51
▸ GPR39 O43194 1/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ CCNA2 P20248 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304820 0.90 CDK2 (0.53) CDK2GSK3BGPR39KMT2AMEN1
SCHEMBL12953177 0.90 CDK2 (0.68) CDK2GSK3BCCNA2CCNA1
SCHEMBL13305418 0.81 CDK2 (0.63) CDK2GSK3BGPR39KMT2AMEN1
SCHEMBL13289158 0.81 CDK2 (0.63) CDK2GSK3BGPR39KMT2AMEN1
SCHEMBL13305297 0.81 CDK2 (0.77) CDK2GSK3BGPR39KMT2AMEN1
SCHEMBL13304831 0.80 CDK2 (0.58) CDK2GSK3BKMT2AMEN1NPC1
SCHEMBL13146196 0.79 GSK3B (0.55) CDK2GSK3BGPR39KMT2AMEN1
SCHEMBL12953060 0.79 GSK3B (0.70) CDK2GSK3BCCNA2CCNA1
SCHEMBL13305311 0.79 GSK3B (0.79) CDK2GSK3BCYP1A2CYP3A4
SCHEMBL12953818 0.78 CDK2 (0.67) CDK2GSK3BCCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback